KR100428702B1 - Feed additive compositions for animals comprising polyethoxylated alpha tocopherol ester derivatives - Google Patents
Feed additive compositions for animals comprising polyethoxylated alpha tocopherol ester derivatives Download PDFInfo
- Publication number
- KR100428702B1 KR100428702B1 KR10-2002-0025267A KR20020025267A KR100428702B1 KR 100428702 B1 KR100428702 B1 KR 100428702B1 KR 20020025267 A KR20020025267 A KR 20020025267A KR 100428702 B1 KR100428702 B1 KR 100428702B1
- Authority
- KR
- South Korea
- Prior art keywords
- alpha
- succinate
- tocopheryl
- methylpolyethyleneglycolyl
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 유효성분으로서 다음 화학식 1의 폴리에톡실화 알파 토코페롤 에스테르 유도체를 함유하는 동물용 사료첨가제 조성물에 관한 것이다:The present invention relates to a feed additive composition for animals containing a polyethoxylated alpha tocopherol ester derivative of the formula (1) as an active ingredient:
[화학식 1][Formula 1]
상기 식에서,Where
R은 CH3OCH2CH2(OCH2CH2)n이며, 여기서 n은 2∼400의 정수이다.R is CH 3 OCH 2 CH 2 (OCH 2 CH 2 ) n, where n is an integer from 2 to 400.
본 발명의 동물용 사료첨가제 조성물을 가축에 급식할 경우, 육질개선제의 효과, 체중증대 효과 및 사료 요구율을 극대화시킬 수 있어서, 전 축종 모든 사료에 비타민 E의 공급원으로서 사용될 수 있다.When feeding the animal feed additive composition of the present invention to livestock, it is possible to maximize the effect of the meat improver, weight gain effect and feed requirements, it can be used as a source of vitamin E in all feeds.
Description
본 발명은 다음 화학식 1의 폴리에톡실화 알파 토코페롤 에스테르 유도체를 함유하는 동물용 사료첨가제 조성물 및 그 제조방법에 관한 것이다:The present invention relates to a feed additive composition for animals containing a polyethoxylated alpha tocopherol ester derivative of the following formula 1 and a method for preparing the same:
상기 식에서,Where
R은 CH3OCH2CH2(OCH2CH2)n이며, 여기서 n은 2∼400의 정수이다.R is CH 3 OCH 2 CH 2 (OCH 2 CH 2 ) n, where n is an integer from 2 to 400.
하기 화학식 2로 표시되는 비타민 E(DL-알파-토코페롤)은 생명체에 항산화제로 널리 사용되며, 최근 들어 임상적용 분야가 확장되고 있고, 이에 대한 요구도 증가하고 있는 추세이다:Vitamin E (DL-alpha-tocopherol) represented by the following Chemical Formula 2 is widely used as an antioxidant in living organisms, and recently, the field of clinical application is expanding, and the demand for this is increasing:
비타민 E는 벤젠고리에 하이드록시기를 가지고 있는 화합물로써 물리적으로는 물에 용해되지 않는 지용성의 특징이 있고, 비타민 E 자체는 일반적으로 산화가 잘 되기 때문에 화학적으로 불안정할 뿐만 아니라 산화 생성물인 토코페롤 퀴논은 비타민 E의 생물학적 활성을 갖지 못한다. 따라서, 비타민 E의 산화를 방지하기 위하여 보다 안정화 된 유도체들로 전환시켜 사용하는데, 이러한 유도체들로는 초산 토코페롤, 팔미틴산 토코페롤, 호박산 토코페롤 등이 있다. 이들은 비타민 E 자체에 비해 비교적 안정도가 높기 때문에 보관 및 수송상의 장점을 가지고 있고, 약물학적인 목적으로는 허용 가능한 안정도를 가지고 있기 때문에 비타민 E의 대체물 제조용으로 효과적이다.Vitamin E is a compound having a hydroxy group in the benzene ring, which is physically insoluble in water, and because vitamin E itself is generally oxidized, it is not only chemically unstable but also an oxidation product of tocopherol quinone. Does not have the biological activity of vitamin E. Therefore, in order to prevent the oxidation of vitamin E is converted to more stabilized derivatives, such derivatives include tocopherol acetate, palmitate tocopherol, succinate tocopherol and the like. They have advantages of storage and transport because of their relatively high stability compared to vitamin E itself, and are effective for the manufacture of substitutes for vitamin E because of their acceptable stability for pharmacological purposes.
또한 경구 투여의 경우에 있어서, 상술한 비타민 E 에스테르 화합물들은 생체내의 장관을 통해 흡수될 때, 췌액 효소 및 장 효소와 접촉하면 완전히 가수분해 되어 토코페롤 형태로 생체 내에 흡수된다.In addition, in the case of oral administration, the vitamin E ester compounds described above are completely hydrolyzed upon contact with pancreatic enzymes and intestinal enzymes when absorbed through the intestinal tract in vivo, and are absorbed in vivo in the form of tocopherols.
이러한 이유로 전 축(畜)종 모든 사료에 비타민 E 대체물을 많이 사용하고 있으며, 특히 양돈사료에 비타민 E 공급원으로 초산 토코페롤을 널리 사용하고 있고, 돈육의 육질 개선제로서의 효과가 있는 것으로 널리 알려지고 있다.For this reason, vitamin E substitutes are widely used in all feedstocks, and tocopherol acetate is widely used as a source of vitamin E in pig feed, and it is widely known that it is effective as a meat improver of pork.
상기의 활성 화합물들이 비타민 E 공급을 위한 동물용 사료첨가제로 사용되기 위해서는 물 또는 유기용매 등에 용해시켜 희석하여 액상으로 제조되거나, 사료첨가제로 사용 가능한 고상의 부형제에 흡착시켜 고상의 형태로 제조되어야 한다. 그러나, 상기의 활성 화합물들의 물성이 점성의 액체이므로 소량을 첨가해야 하는 사료 제조공정에 그 자체로 사용할 수 없거나, 사용한다해도 난점이 많다.In order to be used as an animal feed additive for supplying vitamin E, the active compounds must be prepared in a liquid phase by dissolving in water or an organic solvent and diluting them, or by adsorbing to a solid excipient that can be used as a feed additive. . However, since the physical properties of the above active compounds are viscous liquids, they cannot be used by themselves in the feed manufacturing process to which a small amount is added, or they are difficult to use.
이에 따라 본 발명자들은 본 발명에서 사용된 폴리에톡실화 알파 토코페롤 에스테르 유도체들이 물에 대한 용해도가 크고, 산화가 잘되지 않으며, 화학적으로 안정도를 가지고 있으며, 이 유도체가 비타민 E의 공급원으로서 유용하다는 사실에 착안하여 동물용 사료첨가제 조성물로서 개발하여 본 발명을 완성하기에 이른 것이다.Accordingly, the inventors have found that the polyethoxylated alpha tocopherol ester derivatives used in the present invention have high solubility in water, are not oxidized well, are chemically stable, and are useful as a source of vitamin E. Focusing on the development of the animal feed additive composition to complete the present invention.
따라서, 본 발명의 목적은 상기 화학식 1의 유도체를 포함하는 동물용 사료첨가제 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide an animal feed additive composition comprising the derivative of Formula 1.
또한 본 발명의 다른 목적은 유효성분으로서 상기 화학식 1의 유도체를 부형제에 용해 또는 흡착시켜서 고상 또는 액상 제제를 얻는 상기 동물용 사료첨가제 조성물의 제조방법을 제공한다.Another object of the present invention is to provide a method for preparing the animal feed additive composition for obtaining a solid or liquid formulation by dissolving or adsorbing the derivative of Formula 1 as an active ingredient in an excipient.
본 발명의 동물용 사료첨가제 조성물은 유효성분으로서 다음 화학식 1의 폴리에톡실화 알파 토코페롤 에스테르 유도체를 함유한다:Animal feed additive composition of the present invention contains a polyethoxylated alpha tocopherol ester derivative of the formula (1) as an active ingredient:
[화학식 1][Formula 1]
상기 식에서,Where
R은 CH3OCH2CH2(OCH2CH2)n이며, 여기서 n은 2∼400의 정수이다.R is CH 3 OCH 2 CH 2 (OCH 2 CH 2 ) n, where n is an integer from 2 to 400.
상기 화학식 1의 화합물 중 바람직한 그룹은 n이 2∼50의 정수인 R의 그룹을 가진 화합물이다.Preferred groups in the compound of Formula 1 are those having a group of R where n is an integer from 2 to 50.
본 발명에 따른 동물용 사료첨가제 조성물은 상기 화학식 1의 유도체를 부형제에 용해 또는 흡착시켜 고상 또는 액상의 형태로 제제화될 수 있다.Animal feed additive composition according to the invention can be formulated in the form of a solid or liquid by dissolving or adsorbing the derivative of Formula 1 in the excipient.
제제화를 위해 사용된 부형제에는 흡착제, 무기 또는 유기 매개체 또는 식물유를 들 수 있다. 흡착제에는 제오실(zeosil), 당, 셀룰로즈, 분유, 육골분, 굵고 가는 곡물가루, 옥수수 속대(corncob), 전분 또는 탈지강을 포함한다. 또한 무기 또는 유기 매개체에는 용매로서 사용되는 물 또는 에탄올, 염화나트륨, 탄산칼슘, 중탄산염, 산화알루미늄, 실리카, 알루미나, 침전된 또는 콜로이드성 이산화규소 또는 인산염을 포함한다. 식물유로서는 콩기름, 피마자유, 면실유, 팜유 등을 들 수 있다.Excipients used for formulation include adsorbents, inorganic or organic media or vegetable oils. Adsorbents include zeosil, sugar, cellulose, powdered milk, bone meal, coarse flour, corncob, starch or skim steel. Inorganic or organic media also include water or ethanol, sodium chloride, calcium carbonate, bicarbonate, aluminum oxide, silica, alumina, precipitated or colloidal silicon dioxide or phosphate used as solvent. Soybean oil, castor oil, cottonseed oil, palm oil etc. are mentioned as vegetable oil.
구체적인 폴리에톡실화 알파 토코페롤 에스테르 유도체의 제제를 언급하면 다음과 같다. 액상 제제로는 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6)-에탄올/물; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11)-에탄올/물; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=44)-에탄올/물 액제이며, 고상 제형으로는 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6)-옥수수 속대; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11)-옥수수 속대; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=44)-옥수수 속대; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6)-탈지강; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11)-탈지강; DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=44)-탈지강이다.Referring to the preparation of specific polyethoxylated alpha tocopherol ester derivatives are as follows. Liquid formulations include DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 6) -ethanol / water; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11) -ethanol / water; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44) -ethanol / water solution; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate in solid form (n = 6) -corn cob; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11) -corn cob; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44) -corn cob; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 6) -degreasing steel; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11) -degreasing steel; DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44) -degreasing steel.
본 발명에 따른 제제들은 비타민 E 공급을 위한 동물용 사료첨가제에 적합하며, 가축용 사료첨가제 및 어류용 사료첨가제로 특히 바람직하다.The preparations according to the invention are suitable for animal feed additives for the supply of vitamin E, and are particularly preferred as feed additives for livestock and fish feed additives.
화학식 1의 알파-토코페롤 에스테르 유도체의 제형에 대한 제조는 바람직하게는 액상일 경우는 화학식 1의 알파-토코페롤 에스테르 유도체에 가용(운반)매개체를 가하여 용해시키면 되고, 고상일 경우는 적합한 용매 중에 화학식 1의 알파-토코페롤 에스테르 유도체와 부형제를 가하고, 필요에 따라 가열하고 용매를 증발시켜 수행한다. 이 때, 알파-토코페롤 에스테르 유도체 및 부형제를 3:2 내지 1:99의 비율로 혼합하여 알파-토코페롤 에스테르 유도체 제형의 농도가 60% 내지 1% (w/w)가 된다.Preparation of the formulation of the alpha-tocopherol ester derivative of formula (1) is preferably carried out by dissolving a soluble (carrying) medium in the alpha-tocopherol ester derivative of formula (1) in the case of liquid phase, and in a suitable solvent in the case of solid phase. Alpha-tocopherol ester derivatives and excipients are added, followed by heating as necessary and evaporation of the solvent. At this time, the alpha-tocopherol ester derivative and the excipient are mixed in a ratio of 3: 2 to 1:99 so that the concentration of the alpha-tocopherol ester derivative formulation is 60% to 1% (w / w).
제형 제조시(고형) 적합한 용매는 물뿐만 아니라 불활성 유기용매 예를 들면, 알코올(메탄올 또는 에탄올), 에테르, 탄화수소(톨루엔, 벤젠 및 크실렌)이다.Suitable solvents for formulation preparation (solid) are water as well as inert organic solvents such as alcohols (methanol or ethanol), ethers, hydrocarbons (toluene, benzene and xylene).
상기 제형을 이용하여 동물용 사료에 첨가시 사료 중에 활성 화합물의 농도는 사료의 총 중량을 기준으로 하여 보통 1.0 내지 500ppm (비타민 E 기준) 이고 바람직하게는 10 내지 200 ppm이다.The concentration of the active compound in the feed when added to the animal feed using the formulation is usually 1.0 to 500 ppm (based on vitamin E) and preferably 10 to 200 ppm based on the total weight of the feed.
이미 언급한 바대로, 활성물질은 인체 및 동물용 비타민 E 공급원으로 사용 가능하고 특히 동물용 및 어류용에 적합하다. 해당되는 가축은 다음과 같다: 소, 말, 돼지, 양, 염소, 고양이, 개, 낙타와 같은 포유류, 밍크 및 친칠라와 같은 털을 가진 동물, 동물원에 있는 동물 및 마우스 및 래트와 같은 실험용 동물 ; 거위, 닭, 칠면조, 오리, 비둘기와 같은 조류, 및 앵무새 및 잉꼬와 같은 실험실 조류 ; 잉어, 송어, 연어, 텐취 및 뱀장어와 같은 어류, 장식용 어류 및 수족관 어류 ; 악어 및 뱀과 같은 파충류.As already mentioned, the active substance can be used as a source of vitamin E for humans and animals and is particularly suitable for animals and fish. Animals of interest include: cattle, horses, pigs, sheep, goats, cats, dogs, mammals such as camels, animals with hair such as mink and chinchillas, animals in zoos and laboratory animals such as mice and rats; Birds such as geese, chickens, turkeys, ducks, pigeons, and laboratory birds such as parrots and macaws; Fish such as carp, trout, salmon, tenches and eel, ornamental fish and aquarium fish; Reptiles such as crocodiles and snakes.
본 발명을 실시예를 들어 설명하면 다음과 같으나, 본 발명이 이들 실시예에 한정되지는 않는다.The present invention will be described with reference to Examples, but the present invention is not limited to these Examples.
실시예 1. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=6)-에탄올/물 액제 제조Example 1 Preparation of DL-alpha-tocopheryl-ω-methylpolyethyleneglycoryl-succinate (n = 6) -ethanol / water liquid
DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6, 평균 분자량 : 863) 60g을 95% 에탄올 40g에 용해시켜 60%(w/w)의 표제화합물 100g을 수득한다.60 g of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 6, average molecular weight: 863) is dissolved in 40 g of 95% ethanol to give 60 g (w / w) of 100 g of the title compound. .
실시예 2. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11)-에탄올/물 액제 제조Example 2. Preparation of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11) -ethanol / water liquid
DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11, 평균 분자량 : 1063) 60g을 95% 에탄올 40 g에 용해시켜 60%(w/w)의 표제화합물 100g을 수득한다.60 g of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11, average molecular weight: 1063) was dissolved in 40 g of 95% ethanol to give 60 g (w / w) of 100 g of the title compound. do.
실시예 3. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=44)-에탄올/물 액제 제조Example 3. Preparation of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44) -ethanol / water liquid
DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=44, 평균분자량: 2153) 60g을 95% 에탄올 40 g에 용해시켜 60%(w/w)의 표제화합물 100g을 수득한다.60 g of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44, average molecular weight: 2153) was dissolved in 40 g of 95% ethanol to give 60 g (w / w) of 100 g of the title compound. do.
실시예 4. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=6)-옥수수 속대 제형 제조Example 4. Preparation of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 6) -corn cob formulation
DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6, 평균 분자량 : 863) 60g을 메틸렌디클로라이드 100ml에 용해시킨 다음 옥수수 속대 240g을 상기 용액에 투입후 상온에서 30분 내지 1시간 교반한다. 상기 혼합물을 감압하에서 메틸렌디클로라이드를 증발시키면서 20%(w/w)의 고상의 표제화합물 300g을 수득한다.60 g of DL-alpha-tocopheryl-ω-methyl polyethyleneglycolyl-succinate (n = 6, average molecular weight: 863) was dissolved in 100 ml of methylene dichloride, and 240 g of corncob was added to the solution, followed by 30 minutes at room temperature. Stir for 1 hour. The mixture was distilled off under reduced pressure to afford 20 g (w / w) of 300 g of the title compound as a solid.
실시예 5. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11)-옥수수 속대 제형 제조Example 5 DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11) -corn cob formulation
실시예 4의 토코페롤 유도체(n=6) 대신에 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11, 평균 분자량 : 1063) 60g을 이용하여 표제화합물 300g을 수득한다.Instead of the tocopherol derivative (n = 6) of Example 4, 300 g of the title compound is obtained using 60 g of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11, average molecular weight: 1063). .
실시예 6. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=44)-옥수수 속대 제형 제조Example 6. Preparation of DL-alpha-tocopheryl-ω-methylpolyethyleneglycoryl-succinate (n = 44) -corn cob formulation
실시예 4의 토코페롤 유도체(n=6) 대신에 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=44, 평균 분자량 : 2153) 60g을 이용하여 표제화합물 300g을 수득한다.Instead of the tocopherol derivative (n = 6) of Example 4, 300 g of the title compound is obtained using 60 g of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44, average molecular weight: 2153). .
실시예 7. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6)-탈지강 제형 제조Example 7 DL-alpha-tocopheryl-ω-methylpolyethyleneglycoryl-succinate (n = 6) -degreasing steel formulation preparation
실시예 4의 옥수수 속대 240g 대신 탈지강 240g를 이용하여 표제 화합물 300g을 수득한다.Instead of 240 g of corncob of Example 4, 240 g of skim steel is used to obtain 300 g of the title compound.
실시예 8. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=11)-탈지강 제형 제조Example 8 DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 11) -degreasing steel formulation preparation
실시예 4의 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6,평균 분자량:863) 대신 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=11,평균 분자량:1063) 60g와 옥수수 속대 대신 탈지강 240g을 이용하여 표제 화합물 300g를 수득한다.DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate instead of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 6, average molecular weight: 863) of Example 4 n = 11, average molecular weight: 1063) and 300 g of the title compound were obtained using 240 g of degreasing steel instead of corncob.
실시예 9. DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=44)-탈지강 제형 제조Example 9 DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 44) -degreasing steel formulation preparation
실시예 4의 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트(n=6,평균 분자량:863) 대신 DL-알파-토코페릴-ω-메틸폴리에틸렌글라이코릴-석시네이트 (n=44,평균 분자량:2153) 60g와 옥수수 속대 대신 탈지강 240g을 이용하여 표제 화합물 300g를 수득한다.DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (Example 4 instead of DL-alpha-tocopheryl-ω-methylpolyethyleneglycolyl-succinate (n = 6, average molecular weight: 863) n = 44, average molecular weight: 2153) 300 g of the title compound were obtained using 60 g of degreasing steel instead of corncob.
실험예 1. 비육돈의 성장과 도체품질에 미치는 영향평가Experimental Example 1. Evaluation of the effect on the growth and carcass quality of finishing pigs
표준 대조 화합물인 초산 토코페롤 대비 화학식 1의 화합물(n= 11)을 실시예 2의 에탄올/물 액제로 하여 비육돈에 사료와 함께 투여시 비육돈의 성장과 도체품질에 미치는 영향을 규명하기 위하여 유효성 시험군의 체중, 사료 섭취량, 일당 증체량, 사료 요구율(사료섭취량/체중증대, 수치가 낮을수록 효율이 좋음) 및 도체등급을 측정 비교하였다.Efficacy test group to investigate the effect of the compound of formula 1 (n = 11) compared to the standard control compound tocopherol (n = 11) as the ethanol / water solution of Example 2 on the growth and carcass quality of the finishing pig when administered with feed Body weight, feed intake, weight gain per day, feed requirement (feed intake / weight gain, lower efficiency were better) and carcass rating were compared.
실험 동물의 수는 총 160수(5마리/우리(pen)), 평균 체중 78±2 Kg(50두) 1 반복, 74±2 Kg(50두) 2 반복, 70±2 Kg(50두) 3 반복이며, 암수 비율은 처리간에 차이가 없도록 같은 비율로 조정하며, 삼원교잡종 비육돈을 사용하여 상기 실험을 실시하였다.The total number of test animals was 160 (5 / pen), average weight 78 ± 2 Kg (50 heads) 1 repetition, 74 ± 2 Kg (50 heads) 2 repetition, 70 ± 2 Kg (50 heads) Three repetitions, the male and female ratio was adjusted to the same ratio so that there is no difference between treatments, the experiment was carried out using ternary hybrid pigs.
1. 실험방법1. Experimental method
대상 축(畜)의 체중을 측정한 후 1 주일간 사료를 급여하면서 투쟁에 대한 순화과정을 1 주일 갖고 그 이후 다시 체중을 측정한 후 시험사료를 급여한다.After weighing the subject's shaft, feed is fed for one week, followed by a week of purifying the struggle, then weighed again, and then fed test feeds.
시험사료의 경우 비육돈 시험사료의 에너지 단백질을 맞춘 기초사료와 비타민 미네랄 혼합물만을 별도로 구입하되 비타민 E는 기존의 비타민 제제를 구입한다. 화합물 1의 화합물은 별도로 공급 받아 사료배합에 사용한다. 사료 및 물은 자유로이 섭취할 수 있도록 하였고, 총 6주간 사양시험을 실시하며 매 3주 간격으로 체중 및 사료 요구율을 측정한다. 시험 종료시 도축하고 등급판정을 받는다.In the case of the test feed, only the basic food and the vitamin-mineral mixture prepared with the energy protein of the hog test feed are purchased separately, but the vitamin E is purchased with the existing vitamin preparation. Compound 1 is supplied separately and used in feed formulations. Feed and water were allowed to be freely consumed, followed by a total of six weeks of specification testing, and body weight and feed requirements were measured every three weeks. Slaughter and graded at the end of the test.
2. 시험결과2. Test result
본 발명의 화합물은 상기 실험예에서도 알 수 있듯이 동물용 사료에 비타민 E의 공급원으로 사용할 수 있고 특히 양돈사료에 있어서 기존에 널리 사용되고 있는 초산 토코페롤보다 돈육의 육질개선제의 효과가 월등하고, 초산토코페롤 사용시 기대할 후 없었던 체중증대 효과 및 사료 요구율을 극대화시킬 수 있으므로 전 축종 모든 사료에 비타민 E의 공급원으로 사용될 수 있다.The compound of the present invention can be used as a source of vitamin E in animal feed as can be seen in the above experimental example, and in particular, the effect of the meat improver of pork is superior to the conventionally widely used tocopherol acetate in pig feed, and when using tocopherol acetate It can be used as a source of vitamin E in all feeds because it can maximize the weight gain effect and feed requirements that were not expected.
Claims (8)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010029224 | 2001-05-26 | ||
KR20010029224 | 2001-05-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020090293A KR20020090293A (en) | 2002-12-02 |
KR100428702B1 true KR100428702B1 (en) | 2004-04-28 |
Family
ID=19710000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0025267A KR100428702B1 (en) | 2001-05-26 | 2002-05-08 | Feed additive compositions for animals comprising polyethoxylated alpha tocopherol ester derivatives |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100428702B1 (en) |
WO (1) | WO2002096217A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI329214B (en) | 2003-12-18 | 2010-08-21 | Sharp Kk | Display element and display device, driving method of display element, and program |
AU2011213557B2 (en) | 2010-02-05 | 2015-05-07 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
CN104222691B (en) * | 2014-10-10 | 2016-05-11 | 珠海海龙生物科技有限公司 | The scrod feed of a kind of raw fish and application thereof |
CN104522417B (en) * | 2014-12-30 | 2017-05-24 | 青岛农业大学 | Micro-granular feed for larva fish of bostrichthys sinensis and preparation method of micro-granular feed |
CN105076754A (en) * | 2015-07-17 | 2015-11-25 | 句容市天贵农副产品有限公司 | Marinated old goose meat quality improving feed composition |
CN104996799A (en) * | 2015-07-17 | 2015-10-28 | 句容市天贵农副产品有限公司 | Feed composition for improving tenderness of old goose meat |
EP3383371B1 (en) | 2015-12-09 | 2024-05-01 | Avecho Biotechnology Limited | Pharmaceutical formulation |
US20200060311A1 (en) * | 2016-12-09 | 2020-02-27 | Avecho Biotechnology Limited | A method for improving performance parameters of an animal |
JP7198754B2 (en) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | Method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10150924A (en) * | 1996-11-20 | 1998-06-09 | Chubu Shiryo Kk | Sesame lignan material, egg enriched with vitamins e, production of enriched egg and health food based on enriched egg |
JPH10155429A (en) * | 1996-11-27 | 1998-06-16 | Showa Denko Kk | Method for supplying vitamin e to animals and tocopherol phosphate for animals or its salts composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR940010888B1 (en) * | 1991-03-29 | 1994-11-19 | 주식회사 태평양 | Polyethoxylated vitamin e and preparing method thereof |
JPH0570793A (en) * | 1991-09-10 | 1993-03-23 | Nissei Baadeishie Kk | Granular lipid composition |
JPH06279439A (en) * | 1993-03-25 | 1994-10-04 | Kanto Denka Kogyo Co Ltd | New compound and its production |
US5869704A (en) * | 1998-08-24 | 1999-02-09 | Eastman Chemical Company | Water-dispersible or water-soluble D-tocotrienol compounds and methods for making therefor |
-
2002
- 2002-05-08 KR KR10-2002-0025267A patent/KR100428702B1/en not_active IP Right Cessation
- 2002-05-15 WO PCT/KR2002/000908 patent/WO2002096217A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10150924A (en) * | 1996-11-20 | 1998-06-09 | Chubu Shiryo Kk | Sesame lignan material, egg enriched with vitamins e, production of enriched egg and health food based on enriched egg |
JPH10155429A (en) * | 1996-11-27 | 1998-06-16 | Showa Denko Kk | Method for supplying vitamin e to animals and tocopherol phosphate for animals or its salts composition |
Also Published As
Publication number | Publication date |
---|---|
WO2002096217A1 (en) | 2002-12-05 |
KR20020090293A (en) | 2002-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2062376A1 (en) | Medicinal composition | |
KR20130126642A (en) | Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance | |
Pinchasov et al. | Effect of short-chain fatty acids on voluntary feed of broiler chicks | |
KR100428702B1 (en) | Feed additive compositions for animals comprising polyethoxylated alpha tocopherol ester derivatives | |
Wojick et al. | Pharmacokinetics of long-acting ceftiofur crystalline-free acid in helmeted guineafowl (Numida meleagris) after a single intramuscular injection | |
EP0170538B1 (en) | Use of certain compounds in livestock food as growth promotants | |
US4711897A (en) | Animal feed methods and compositions using cysteamine | |
BG107038A (en) | Composition against endopa gel | |
CA1069824A (en) | Coccidiocidal combination | |
KR910002420B1 (en) | Animal growth promotant | |
TW201221066A (en) | Lauric acid distillate for animal feed | |
US4970208A (en) | Feed additive for improving growth in agricultural animals | |
JPS5874607A (en) | Anticoccidial composition | |
KR20110031360A (en) | Nifurtimox for treating diseases caused by trichomonadida | |
KR100450274B1 (en) | Feed additive compositions for animals comprising polyethoxylated ascorbic acid derivatives | |
US7045150B2 (en) | Tellurium containing nutrient formulation and process for enhancing the cumulative weight gain or feed efficacy in poultry | |
US20190191740A1 (en) | Methods to Promote Growth and Improve Feed Conversion in Animals | |
GB1586272A (en) | Coccidiocidal combination | |
RU2323718C2 (en) | Medicine to treat young stock gastrointestinal diseases | |
KR100533304B1 (en) | Polyethoxylated alpha tocopherol ester derivatives and process for preparing the same | |
SU1676572A1 (en) | Vitamin feeding device for poultry | |
JPH06701B2 (en) | Veterinary composition | |
RU2415848C2 (en) | Growth enhancement method | |
EP0104836B1 (en) | Feed compositions containing a (1-oxo-2-pyridyl) disulfide | |
RU2051592C1 (en) | Method of piglet and chicken-broilers breeding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |